<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03148080</url>
  </required_header>
  <id_info>
    <org_study_id>REBAWF10217</org_study_id>
    <secondary_id>5R21CA191989-02</secondary_id>
    <nct_id>NCT03148080</nct_id>
  </id_info>
  <brief_title>Work Ability in Young Adult Survivors</brief_title>
  <acronym>WAYS</acronym>
  <official_title>Work Ability in Young Adult Survivors (WAYS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To document levels of labor force participation, occupation, educational attainment, and
      financial toxicity following cancer treatment in YA cancer survivors aged 25-34 years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This observational, cross-sectional study will recruit 200 YA survivors through the Wake
      Forest National Cancer Institute Community Oncology Research Program (NCORP) Research Base
      (WF NCORP RB). Data will be collected using a web-based interface and will capture physical,
      psychosocial and cognitive late effects; work ability; work-related outcomes, including labor
      force participation, occupation, work place characteristics, and educational attainment;
      survivor characteristics; and cancer diagnosis/treatment information (from clinical records).
      We will evaluate the relationships among these measures using the theoretical framework to
      guide statistical analysis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2, 2018</start_date>
  <completion_date type="Anticipated">September 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Work Ability Index</measure>
    <time_frame>Baseline Visit</time_frame>
    <description>Items selected from self-report measure of current work ability compared to lifetime best, physical and mental demands of job, impact of illness on work ability, and perceived future work ability.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Work Limitations Questionnaire</measure>
    <time_frame>Baseline Visit</time_frame>
    <description>Self-report measure of impact of chronic health conditions/treatment on job performance</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PROMIS Applied Cognition - Abilities</measure>
    <time_frame>Baseline Visit</time_frame>
    <description>8-item self-report measure of memory, concentration, and executive function over past 7 days.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PROMIS Applied Cognition - General Concerns</measure>
    <time_frame>Baseline Visit</time_frame>
    <description>8-item self-report measure of concerns regarding speed of thinking, difficulty in maintaining attention, and impact of mental mistakes on quality of life in the past 7 days.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CogstateTM- Version 7.0</measure>
    <time_frame>Baseline Visit</time_frame>
    <description>Brief self-administered, online cognitive assessment of 4 neurocognitive domains: processing speed, attention, working memory and visual learning memory.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PROMIS-29 version 2.0</measure>
    <time_frame>Baseline Visit</time_frame>
    <description>29-item self-report measure including 4 items each for the following domains: physical function, anxiety, depression, fatigue, sleep disturbance, social function and pain interference; plus 1 item measuring average pain intensity. Physical and social function domains assess current function; items for all other domains reference the past 7 days.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PROMIS Physical Function Short Form</measure>
    <time_frame>Baseline Visit</time_frame>
    <description>Self-report measure of capability for physical activities (i.e., walking/mobility and instrumental activities of daily living). Assesses current function. Will use only the 4 items that are unique to this measure (will not duplicate the 4 items already included in PROMIS-29)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comprehensive Score for Financial Toxicity (COST)</measure>
    <time_frame>Baseline Visit</time_frame>
    <description>11-item self-report measure of financial distress experienced in response to cancer and its treatment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>NIH Toolbox - Positive Affect, Life Satisfaction, Meaning &amp; Purpose</measure>
    <time_frame>Baseline Visit</time_frame>
    <description>4-item short form for positive affect, 5-item short form for life satisfaction, and 4-item short form for meaning and purpose.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Flourishing Scale</measure>
    <time_frame>Baseline Visit</time_frame>
    <description>8-item self-report measure of self-perceived success in important areas such as relationships, self-esteem, purpose, and optimism. The scale provides a single psychological well-being score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Posttraumatic Growth Inventory</measure>
    <time_frame>Baseline Visit</time_frame>
    <description>10-item measures of self-reported positive psychological changes following a highly stressful experience.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of Worklife Module (QWL) GSS</measure>
    <time_frame>Baseline Visit</time_frame>
    <description>Module developed for GSS, a high-quality, widely-used survey . The items address current job characteristics, employment conditions and work environment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Support at Workplace</measure>
    <time_frame>Baseline Visit</time_frame>
    <description>8-item self-report measure of amount of support received/satisfaction with support from supervisor from Nordic Study on Cancer and Work.</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Cancer Survivors</condition>
  <arm_group>
    <arm_group_label>Age 25-29 years old</arm_group_label>
    <description>Data collection: brief cognitive testing; detailed questionnaire assessing occupation, education status, a variety of work measures, and self-reported physical, psychosocial, and cognitive function; medical history, cancer treatment information, and medication use.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2-5 five years since diagnosis</arm_group_label>
    <description>Data collection: brief cognitive testing; detailed questionnaire assessing occupation, education status, a variety of work measures, and self-reported physical, psychosocial, and cognitive function; medical history, cancer treatment information, and medication use.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Age 30 - 34 years old</arm_group_label>
    <description>Data collection: brief cognitive testing; detailed questionnaire assessing occupation, education status, a variety of work measures, and self-reported physical, psychosocial, and cognitive function; medical history, cancer treatment information, and medication use.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6-10 years since diagnosis</arm_group_label>
    <description>Data collection: brief cognitive testing; detailed questionnaire assessing occupation, education status, a variety of work measures, and self-reported physical, psychosocial, and cognitive function; medical history, cancer treatment information, and medication use.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data Collection Only:</intervention_name>
    <description>Brief cognitive testing; questionnaire assessing occupation, education status, variety of work measures, self-reported physical, psychosocial and cognitive function; medical history, cancer treatment information and medication use.</description>
    <arm_group_label>Age 25-29 years old</arm_group_label>
    <arm_group_label>2-5 five years since diagnosis</arm_group_label>
    <arm_group_label>Age 30 - 34 years old</arm_group_label>
    <arm_group_label>6-10 years since diagnosis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        YA survivors between ages 25-34 were selected because they are relatively early in their
        career trajectory and represents AYA cancer survivors. This age range allows comparison to
        national benchmarks on work-related outcomes as it matches exactly the age range examined
        in the national employment statistics. We chose 2 years post diagnosis to allow time for
        acute effects of cancer treatment to stabilize and because many survivors are likely to
        have returned to work. The 10-year post-diagnosis cap limits confounding between time since
        treatment and current age. We will accrue to 4 cells in equal numbers (N=50 for each cell)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  25-34 years of age at time of participation

          -  2 to &lt;10 years post-cancer diagnosis (per diagnostic pathology report).

          -  Diagnosed with first cancer (any type except types listed in exclusion criteria below)
             at age â‰¥15 years.

          -  Ability to understand and willingness to sign a written informed consent document.

          -  Must be able to read and understand English and/or Spanish.

        Exclusion Criteria:

          -  Currently receiving active cancer treatment (acceptable to be on maintenance or
             hormonal therapies).

          -  Life expectancy less than 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>34 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Suzanne C Danhauer, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tammy Vogler, RN</last_name>
    <phone>(336) 713-6907</phone>
    <email>tvogler@wakehealth.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Wake Forest School of Medicine</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robin Rosdhal, RN, OCN</last_name>
      <phone>336-713-6519</phone>
      <email>rosdhal@wakehealth.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 5, 2017</study_first_submitted>
  <study_first_submitted_qc>May 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 10, 2017</study_first_posted>
  <last_update_submitted>April 6, 2018</last_update_submitted>
  <last_update_submitted_qc>April 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

